Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Editorial
Nature Biotechnology 26, 837 (1 August 2008) | doi:10.1038/nbt0808-837
Join the dots
Abstract
These days, governments, industry and experts seem to be putting biotech forward as a solution to almost everything. The mantra has changed from biotech simply providing cures for disease in developed markets to larger, more global problems.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
